You are here Home Resources and guidance Sponsors Bio-Strategy Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Cancellation by sponsor (59) ARTG (14) Date 2025 (4) 2024 (2) 2023 (7) 2022 (19) 2021 (9) 2020 (1) 2019 (8) 2018 (3) 2017 (15) 2014 (3) 2013 (2) Search Sponsor content73 result(s) found, displaying 71 to 73 Bio-Strategy Pty Ltd - Human leukocyte antigen C (HLA-C) typing sera IVDs Cancelled under s41GL(d) of the Act 31 May 2017 Cancellation by sponsor Requested by Bio-Strategy Pty Ltd Bio-Strategy Pty Ltd - Human leukocyte antigen DR (HLA-DR) typing sera IVDs Cancelled under s41GL(d) of the Act 31 May 2017 Cancellation by sponsor Requested by Bio-Strategy Pty Ltd Bio-Strategy Pty Ltd - Multiple human leukocyte antigens (HLA) typing IVDs Cancelled under s41GL(d) of the Act 31 May 2017 Cancellation by sponsor Requested by Bio-Strategy Pty Ltd Pages First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8
Bio-Strategy Pty Ltd - Human leukocyte antigen C (HLA-C) typing sera IVDs Cancelled under s41GL(d) of the Act 31 May 2017 Cancellation by sponsor Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd - Human leukocyte antigen DR (HLA-DR) typing sera IVDs Cancelled under s41GL(d) of the Act 31 May 2017 Cancellation by sponsor Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd - Multiple human leukocyte antigens (HLA) typing IVDs Cancelled under s41GL(d) of the Act 31 May 2017 Cancellation by sponsor Requested by Bio-Strategy Pty Ltd